|
Market Closed -
Other stock markets
|
After hours 16:00:01 | |||
| 65.16 EUR | -1.45% |
|
65.01 | -0.23% |
| 09:24am | Morgan Stanley Adjusts Price Target on Zoetis to $99 From $115, Maintains Overweight Rating | MT |
| 07-15 | Zoetis Inc. Launches Lenivia (Izenivetmab Injection) in Canada and the European Union | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ZTS Stock
- ZOE Stock
- Consensus Zoetis Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
